Your browser doesn't support javascript.
loading
Overcoming Immunological Resistance Enhances the Efficacy of A Novel Anti-tMUC1-CAR T Cell Treatment against Pancreatic Ductal Adenocarcinoma.
Yazdanifar, Mahboubeh; Zhou, Ru; Grover, Priyanka; Williams, Chandra; Bose, Mukulika; Moore, Laura J; Wu, Shu-Ta; Maher, John; Dreau, Didier; Mukherjee, And Pinku.
Afiliação
  • Yazdanifar M; Department of Biological Sciences, University of North Carolina at Charlotte, 9201 University City Boulevard, Charlotte, NC 28223, USA.
  • Zhou R; Department of Biological Sciences, University of North Carolina at Charlotte, 9201 University City Boulevard, Charlotte, NC 28223, USA.
  • Grover P; Department of Biological Sciences, University of North Carolina at Charlotte, 9201 University City Boulevard, Charlotte, NC 28223, USA.
  • Williams C; Department of Biological Sciences, University of North Carolina at Charlotte, 9201 University City Boulevard, Charlotte, NC 28223, USA.
  • Bose M; Department of Biological Sciences, University of North Carolina at Charlotte, 9201 University City Boulevard, Charlotte, NC 28223, USA.
  • Moore LJ; Department of Biological Sciences, University of North Carolina at Charlotte, 9201 University City Boulevard, Charlotte, NC 28223, USA.
  • Wu ST; Department of Biological Sciences, University of North Carolina at Charlotte, 9201 University City Boulevard, Charlotte, NC 28223, USA.
  • Maher J; King's College London, School of Cancer and Pharmaceutical Sciences, Guy's Hospital Campus, Great Maze Pond, London SE1 9RT, UK.
  • Dreau D; Department of Biological Sciences, University of North Carolina at Charlotte, 9201 University City Boulevard, Charlotte, NC 28223, USA.
  • Mukherjee AP; Department of Biological Sciences, University of North Carolina at Charlotte, 9201 University City Boulevard, Charlotte, NC 28223, USA. pmukherj@uncc.edu.
Cells ; 8(9)2019 09 11.
Article em En | MEDLINE | ID: mdl-31514488

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Pancreáticas / Adenocarcinoma / Imunoterapia Adotiva / Mucina-1 / Carcinoma Ductal Pancreático / Antineoplásicos Imunológicos Tipo de estudo: Prognostic_studies Limite: Animals / Female / Humans Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Pancreáticas / Adenocarcinoma / Imunoterapia Adotiva / Mucina-1 / Carcinoma Ductal Pancreático / Antineoplásicos Imunológicos Tipo de estudo: Prognostic_studies Limite: Animals / Female / Humans Idioma: En Ano de publicação: 2019 Tipo de documento: Article